Aptevo Therapeutics APVO
NASDAQ APVO
$1.61 -0.01 (-0.62%)
As of: Oct 22, 2026 · 2:27 PM EDT

Aptevo Therapeutics (APVO) Long-Term Debt Issuances (2016 - 2020)

Updated

Aptevo Therapeutics' Long-Term Debt Issuances came in at $1,000 for Q4 2020.

Analysis

Aptevo Therapeutics (APVO) Long-Term Debt Issuances (2016 - 2020) Analysis & Trends

For FY2020, Aptevo Therapeutics' Long-Term Debt Issuances was $24.73 million.

  • Long-Term Debt Issuances carries a four-year compound annual growth rate of 5.5% (FY2016 to FY2020).
  • Going back by year, Long-Term Debt Issuances was $20 million in FY2016.
  • The Q4 2020 figure represents the highest quarterly Long-Term Debt Issuances since Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Aptevo Therapeutics 1.93 Mn -65.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 1,000.00
Mar 31, 2017 20.00 Mn
Dec 31, 2016 1.96 Mn
API Access

Aptevo Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=APVO&period=max&api_key=YOUR_API_KEY